BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21384745)

  • 1. Effect of warfarin anticoagulation on thrombin generation in patients with idiopathic pulmonary arterial hypertension.
    Jansa P; Hrachovinova I; Ambroz D; Maresova J; Polacek P; Simkova I; Linhart A; Aschermann M
    Bratisl Lek Listy; 2010; 111(11):595-8. PubMed ID: 21384745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
    Choi Q; Kim JE; Hyun J; Han KS; Kim HK
    Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A descriptive evaluation of warfarin use in patients with pulmonary arterial hypertension.
    Irwin AN; Johnson SG; Joline BR; Delate T; Witt DM
    Thromb Res; 2014 May; 133(5):790-4. PubMed ID: 24642007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The application of thrombin generation tests to warfarin anticoagulation monitoring].
    Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL).
    Preston IR; Roberts KE; Miller DP; Sen GP; Selej M; Benton WW; Hill NS; Farber HW
    Circulation; 2015 Dec; 132(25):2403-11. PubMed ID: 26510696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INR vs. thrombin generation assays for guiding VKA reversal: a retrospective comparison.
    Herpers R; van Rossum AP; van Beem RT; Michel WM; Strijbis VJ; Strengers PF; Castel A; Brinkman HJ
    Clin Chem Lab Med; 2015 Jul; 53(8):1227-36. PubMed ID: 25720079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withdrawal of warfarin after deep vein thrombosis: effects of a low fixed dose on rebound thrombin generation.
    Ascani A; Iorio A; Agnelli G
    Blood Coagul Fibrinolysis; 1999 Jul; 10(5):291-5. PubMed ID: 10456621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous thrombin potential (ETP) in plasma from patients with AMI during antithrombotic treatment.
    Brodin E; Seljeflot I; Arnesen H; Hurlen M; Appelbom H; Hansen JB
    Thromb Res; 2009 Feb; 123(4):573-9. PubMed ID: 18474393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin generation and international normalized ratio in inherited thrombophilia patients receiving thromboprophylactic therapy.
    Luna-Záizar H; González-Moncada AI; Padilla-López EL; Ramírez-Anguiano AC; Pacheco-Moisés FP; Velasco-Ramírez SF; Padilla-Romo MG; Borjas-Gutierrez C; Jaloma-Cruz AR
    Thromb Res; 2015 Dec; 136(6):1291-8. PubMed ID: 26493603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
    Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory assessment of warfarin reversal with global coagulation tests versus international normalized ratio in patients with intracranial bleeding.
    Voils SA; Martin EJ; Mohammed BM; Bayrlee A; Brophy DF
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):443-7. PubMed ID: 25699612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo thrombin generation in patients with venous thromboembolic disease or atrial fibrillation on long-term oral anticoagulation.
    Musial J; Brzezinska-Kolarz B; Zólcinski M; Lelakowski J; Szczeklik A
    Clin Appl Thromb Hemost; 2010 Dec; 16(6):614-21. PubMed ID: 20460350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation in pulmonary arterial hypertension: a qualitative systematic review.
    Johnson SR; Mehta S; Granton JT
    Eur Respir J; 2006 Nov; 28(5):999-1004. PubMed ID: 17074918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wide variation in thrombin generation in patients with atrial fibrillation and therapeutic International Normalized Ratio is not due to inflammation.
    Gatt A; van Veen JJ; Bowyer A; Woolley AM; Cooper P; Kitchen S; Makris M
    Br J Haematol; 2008 Sep; 142(6):946-52. PubMed ID: 18573110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
    Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
    Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
    Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
    Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices.
    Couris R; Tataronis G; McCloskey W; Oertel L; Dallal G; Dwyer J; Blumberg JB
    Int J Vitam Nutr Res; 2006 Mar; 76(2):65-74. PubMed ID: 16941417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).
    Olsson KM; Delcroix M; Ghofrani HA; Tiede H; Huscher D; Speich R; Grünig E; Staehler G; Rosenkranz S; Halank M; Held M; Lange TJ; Behr J; Klose H; Claussen M; Ewert R; Opitz CF; Vizza CD; Scelsi L; Vonk-Noordegraaf A; Kaemmerer H; Gibbs JS; Coghlan G; Pepke-Zaba J; Schulz U; Gorenflo M; Pittrow D; Hoeper MM
    Circulation; 2014 Jan; 129(1):57-65. PubMed ID: 24081973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assays of fibrin network properties altered by VKAs in atrial fibrillation - importance of using an appropriate coagulation trigger.
    Ząbczyk M; Blombäck M; Majewski J; Karkowski G; Wallen HN; Undas A; He S
    Thromb Haemost; 2015 Apr; 113(4):851-61. PubMed ID: 25518887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.